Kenneth Schwartz, MD | |
1011 14th Ave Nw, Ardmore, OK 73401-1828 | |
(580) 223-5400 | |
Not Available |
Full Name | Kenneth Schwartz |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 1011 14th Ave Nw, Ardmore, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902820285 | NPI | - | NPPES |
101444 | Other | KS | BLUE CROSS BLUE SHIELD |
627671 | Other | KS | FIRST GUARD |
930112894 | Other | KS | RAILROAD MEDICARE |
100151350B | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 04-24905 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kenneth Schwartz, MD 1943 Rolling Hills Cir, Salina, KS 67401-3738 Ph: (785) 493-1822 | Kenneth Schwartz, MD 1011 14th Ave Nw, Ardmore, OK 73401-1828 Ph: (580) 223-5400 |
News Archive
Roswell Park Comprehensive Cancer Center researchers have once again identified a link between physical inactivity and an increased risk of mortality among cancer patients, emphasizing the health risks of a sedentary lifestyle and the importance of regular exercise as therapy for cancer patients both during and after treatment.
European Development Commissioner Andris Piebalgs announced during a visit to South Africa on Monday that the European Union (E.U.) "will contribute 126 million euros to South Africa's fight against AIDS and tuberculosis (TB)," money that "will be used to improve South Africa's primary health care system, increasing access for patients," Reuters reports.
Orthopaedic surgeons and researchers at NYU Langone Medical Center are the first in the Northeast to use a new device that incorporates sensors, microelectronics and wireless communication to provide real-time data about positioning, balance and tension of ligaments during total knee replacement surgery.
OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.
› Verified 5 days ago
Mark Damon Ii, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Ernest Byron Foster Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Dr. Daniel Ryan Wheeler, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6588 | |
Lindsay Anne Wilson, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6132 Fax: 580-220-6772 | |
Daniel Francis Mckinley, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Dr. Jason Andrew Carter, MD, MHSA, FACEP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 4th Ave Nw Ste 96, Ardmore, OK 73401 Phone: 417-612-3985 | |
Dr. Carl Allen Thompson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 |